Machine Learning‐Based Glycolipid Metabolism Gene Signature Predicts Prognosis and Immune Landscape in Oesophageal Squamous Cell Carcinoma
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Lin Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Machine Learning, Esophageal Neoplasms, Glycolipids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Using machine learning approaches, we developed and validated a novel prognostic model for oesophageal squamous cell carcinoma (ESCC) based on glycolipid metabolism‐related genes. Through integrated analysis of TCGA and GEO datasets, we established a robust 15‐gene signature that effectively stratified patients into distinct risk groups. This signature demonstrated superior prognostic value and revealed significant associations with immune infiltration patterns. High‐risk patients exhibited reduced immune cell infiltration, particularly in B cells and NK cells, alongside increased tumour purity. Single‐cell RNA sequencing analysis uncovered unique cellular composition patterns and enhanced interaction intensities in the high‐risk group, especially within epithelial and smooth muscle cells. Functional validation confirmed MECP2 as a promising therapeutic target, with its knockdown significantly inhibiting tumour progression both in vitro and in vivo. Drug sensitivity analysis identified specific therapeutic agents showing potential efficacy for high‐risk patients. Our study provides both a practical prognostic tool and novel insights into the relationship between glycolipid metabolism and tumour immunity in ESCC, offering potential strategies for personalised treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
- Department of Gastroenterology, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zitieren
APA
Zhu, L., Liang, F., Han, X., Ye, B., & Xue, L. (2025). Machine Learning‐Based Glycolipid Metabolism Gene Signature Predicts Prognosis and Immune Landscape in Oesophageal Squamous Cell Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70434
Vancouver
Zhu L, Liang F, Han X, Ye B, Xue L. Machine Learning‐Based Glycolipid Metabolism Gene Signature Predicts Prognosis and Immune Landscape in Oesophageal Squamous Cell Carcinoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70434
BibTeX
@article{Zhu2025,
author = {Zhu, Lin and Liang, Feng and Han, Xue and Ye, Bin and Xue, Lei},
title = {Machine Learning‐Based Glycolipid Metabolism Gene Signature Predicts Prognosis and Immune Landscape in Oesophageal Squamous Cell Carcinoma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70434}
}
EUVIMED